Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000100

Chairperson & CEO sold 9,500 shares at an average $530.91 ($5,043,689)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-16 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $135.42 $1,286,490 333,943 I
2026-07-16 Sale : show line 2 in the form 10b5-1 −80 $527.31 $42,185 333,863 I
2026-07-16 Sale : show line 3 in the form 10b5-1 −1,400 $528.42 $739,783 332,463 I
2026-07-16 Sale : show line 4 in the form 10b5-1 −3,057 $529.46 $1,618,572 329,406 I
2026-07-16 Sale : show line 5 in the form 10b5-1 −1,924 $530.14 $1,019,999 327,482 I
2026-07-16 Sale : show line 6 in the form 10b5-1 −520 $532.14 $276,712 326,962 I
2026-07-16 Sale : show line 7 in the form 10b5-1 −440 $533.28 $234,644 326,522 I
2026-07-16 Sale : show line 8 in the form 10b5-1 −1,198 $534.31 $640,101 325,324 I
Open-market sales · 9,500 sh · avg $530.91 · $5,043,689

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-16 Exercise or conversion : show line 12 in the form 10b5-1 Stock Option −9,500 331,910 I
Loading xslF345X06/primarydocument.xml…